0000917520-23-000007.txt : 20230125 0000917520-23-000007.hdr.sgml : 20230125 20230125163025 ACCESSION NUMBER: 0000917520-23-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230125 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230125 DATE AS OF CHANGE: 20230125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 23552797 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 8-K 1 iart-20230125.htm 8-K iart-20230125
0000917520false00009175202023-01-252023-01-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 25, 2023

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(Exact Name of Registrant as Specified in its Charter)

Delaware0-2622451-0317849
(State or Other Jurisdiction of Incorporation or Organization) (Commission File Number)(IRS Employer Identification No.)

1100 Campus Road
Princeton, NJ 08540
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (609) 275-0500

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities Registered Pursuant to Section12(b) of the Act:
Title of Each ClassTrading SymbolName of Exchange on Which Registered
Common Stock, Par Value $.01 Per ShareIARTNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On January 25, 2023, Carrie Anderson, Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), notified the Company of her decision to resign, effective as of February 2, 2023, to pursue another professional opportunity.

The Company intends to commence a comprehensive search process to identify a new Chief Financial Officer. In the interim, Mathieu P. Aussermeier, Vice President, Corporate Finance, Investor Relations & Treasurer, and Jeffrey Mosebrook, Senior Vice President, Finance, will assume Ms. Anderson’s financial duties and responsibilities and report to Jan De Witte, the Company’s President and Chief Executive Officer. Mr. Aussermeier will be responsible for treasury, financial planning and analysis, and investor relations. Mr. Mosebrook will oversee accounting, tax, internal audit and global business services. During the interim period, Mr. Mosebrook will serve as the Company’s principal financial officer in addition to serving as principal accounting officer.

Mr. Mosebrook’s biographical information is described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 8, 2022, which is incorporated herein by reference. There are no arrangements or understandings between Mr. Mosebrook and any other person that would require disclosure under Item 401(b) of Regulation S-K. Additionally, there is no family relationship between Mr. Mosebrook and any other person that would require disclosure under Item 401(d) of Regulation S-K and he is not a party to any transactions that would require disclosure under Item 404(a) of Regulation S-K.








SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Date: January 25, 2023By: /s/ Eric I. Schwartz
Eric I. Schwartz
Title:
Executive Vice President, Chief Legal Officer and
Secretary



EX-101.SCH 2 iart-20230125.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 iart-20230125_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 iart-20230125_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material Address Type [Domain] Address Type [Domain] City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Information [Line Items] Entity Information [Line Items] Local Phone Number Local Phone Number Cover [Abstract] Cover [Abstract] Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Document Type Document Type Entity Registrant Name Entity Registrant Name Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 iart-20230125_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Jan. 25, 2023
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Jan. 25, 2023
Entity Registrant Name INTEGRA LIFESCIENCES HOLDINGS CORP
Entity Incorporation, State or Country Code DE
Entity File Number 0-26224
Entity Tax Identification Number 51-0317849
Entity Address, Address Line One 1100 Campus Road
Entity Address, City or Town Princeton
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08540
City Area Code 609
Local Phone Number 275-0500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $.01 Per Share
Trading Symbol IART
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000917520
Amendment Flag false
XML 7 iart-20230125_htm.xml IDEA: XBRL DOCUMENT 0000917520 2023-01-25 2023-01-25 0000917520 false 8-K 2023-01-25 INTEGRA LIFESCIENCES HOLDINGS CORP DE 0-26224 51-0317849 1100 Campus Road Princeton NJ 08540 609 275-0500 false false false false Common Stock, Par Value $.01 Per Share IART NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Sheet http://integralife.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports iart-20230125.htm iart-20230125.xsd iart-20230125_def.xml iart-20230125_lab.xml iart-20230125_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "iart-20230125.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 22 }, "contextCount": 1, "dts": { "definitionLink": { "local": [ "iart-20230125_def.xml" ] }, "inline": { "local": [ "iart-20230125.htm" ] }, "labelLink": { "local": [ "iart-20230125_lab.xml" ] }, "presentationLink": { "local": [ "iart-20230125_pre.xml" ] }, "schema": { "local": [ "iart-20230125.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 27, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "iart", "nsuri": "http://integralife.com/20230125", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230125.htm", "contextRef": "ibc45a0cf5b4844df889e058fc26c3d68_D20230125-20230125", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://integralife.com/role/DocumentandEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230125.htm", "contextRef": "ibc45a0cf5b4844df889e058fc26c3d68_D20230125-20230125", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]", "terseLabel": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]", "terseLabel": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://integralife.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0000917520-23-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000917520-23-000007-xbrl.zip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